ARCHIVES

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

ACCC Joins ONS In Opposing RCT Caregiver Category

March 31, 1989

In Brief: Van Andel Institute to Build Epigenetics Hub

February 28, 2014

In Brief: Kennedy To Stay On Health Committee; Animal Research Bills Probably Dead For This Congress

December 10, 1982

Letter to the Editors: Since 1992, Where Has All The OAM Grant Money Gone?

April 24, 1998

Sole Source Negotiations

October 17, 1975

Genomic Test More Accurate In Predicting Metastasis Than PSA, Tumor Stage & Grade

February 22, 2013